跳至主要内容
临床试验/KCT0003382
KCT0003382已完成未知

A prospective, single-center, single-group clinical trial to evaluate the safety and efficacy of 'ALPIUS' (US-guided HIFU System, ultrasound-guided high-intensity focused ultrasound)

ALPINION MEDICAL SYSTEMS0 个研究点目标入组 29 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
Female

入选标准

  • 1. Adult women over 20 years old
  • 2. Premenopausal or postmenopausal (FSH <40mIU / ml)
  • 3. In case the clinician determines that the uterus size is less than 24 weeks of single pregnancy
  • 4. If myoma is diagnosed by MR or US imaging
  • 5. If myoma size is more than 3cm and less than 12cm
  • 6. Unless HIFU has received other treatment for uterine fibroids
  • 7. Treatment If the guidelines for selection of uterine myoma are met
  • 8. Willing to voluntarily agree to the clinical trial and willing to follow the protocol

排除标准

  • 1. Other pelvic disorders such as other tumors, endometriosis, ovarian tumors, acute pelvic disease
  • 2. If you are pregnant or you are pregnant
  • 3. Severe systemic disease
  • 4. Less than 25% hematocrit
  • 5. If the extensive scarring along the anterior abdominal wall exceeds 50% of the area
  • 6. High intensity focused ultrasound passes through scar, surgical clip
  • 7. MRI taboo (including closure phobia)
  • 8. MRI contrast agents taboo
  • 9. If the number or volume of uterine myomas can not be measured by MRI
  • 10. If the glomerular filtration rate (GFR) is less than 30 ml / min
  • 11. When communication is difficult
  • 12. Can not lie down comfortably
  • 13. Patients who have participated in other clinical trials within the past month
  • 14. Hypervascular myoma
  • 15. In addition, if it is judged by the researcher that participation in this trial is inappropriate

研究者

发起方
ALPINION MEDICAL SYSTEMS

相似试验